Executive Physical

Executive Physical offers busy executives an efficient, cost-effective way to manage their health and reduce medical absences. Thousands of executives from companies throughout the world participate in the Executive Health Programs. For corporate executives who understand the benefits of watching their health, many of the nation's top medical institutions offer "executive health care programs" tailored to their time-pressed needs. The comprehensive physical exams and lengthy physician consultations are conducted with an efficiency and attentiveness worthy of their high-powered clientele. IPA includes a comprehensive medical history review and physical exam by an internal medicine specialist and referrals to sub-specialists, as necessary. It includes a full range of preventive screening tests, a cardiovascular (heart) fitness evaluation. Tailoring the evaluation to the personal health needs and is strictly confidential. You may need to stay for more days if the initial health review identifies issues requiring follow-up. The program blends IPA well-known diagnostic expertise with the latest in preventive medicine. Many a previously undiscovered condition following an executive health exam has been successfully treated. IPA executive health doctors have extensive experience in evaluating health risk factors in healthy people and in people experiencing symptoms of illness or injury. They have access to all of the resources of the Mayo Clinic and can coordinate the care, if you have multiple health concerns.

More Resources

INVESTMENT INTERESTS

SEC. 6002. TRANSPARENCY REPORTS AND REPORTING OF PHYSICIAN
OWNERSHIP OR INVESTMENT INTERESTS.
Part A of title XI of the Social Security Act (42 U.S.C. 1301 et
seq.) is amended by inserting after section 1128F the following new
section:
  SEC. 1128G o42 U.S.C. 1320a–7h.. TRANSPARENCY REPORTS AND REPORTING
OF PHYSICIAN OWNERSHIP OR INVESTMENT INTERESTS.
(a) TRANSPARENCY REPORTS.—
(1) PAYMENTS OR OTHER TRANSFERS OF VALUE.—
(A) IN GENERAL.—On March 31, 2013, and on the
90th day of each calendar year beginning thereafter, any
applicable manufacturer that provides a payment or other
transfer of value to a covered recipient (or to an entity or
individual at the request of or designated on behalf of a
covered recipient), shall submit to the Secretary, in such
electronic form as the Secretary shall require, the following
information with respect to the preceding calendar
year:
(i) The name of the covered recipient.
(ii) The business address of the covered recipient
and, in the case of a covered recipient who is a physician,
the specialty and National Provider Identifier of
the covered recipient.
(iii) The amount of the payment or other transfer
of value.
(iv) The dates on which the payment or other
transfer of value was provided to the covered recipient.
(v) A description of the form of the payment or
other transfer of value, indicated (as appropriate for
all that apply) as—
(I) cash or a cash equivalent;
(II) in-kind items or services;
(III) stock, a stock option, or any other ownership
interest, dividend, profit, or other return on
investment; or
(IV) any other form of payment or other
transfer of value (as defined by the Secretary).
(vi) A description of the nature of the payment or
other transfer of value, indicated (as appropriate for
all that apply) as—
(I) consulting fees;
(II) compensation for services other than consulting;
(III) honoraria;
(IV) gift;
(V) entertainment;
(VI) food;
(VII) travel (including the specified destinations);
(VIII) education;
(IX) research;
(X) charitable contribution;
(XI) royalty or license;
(XII) current or prospective ownership or investment
interest;
(XIII) direct compensation for serving as faculty
or as a speaker for a medical education program;
(XIV) grant; or
(XV) any other nature of the payment or
other transfer of value (as defined by the Secretary).
(vii) If the payment or other transfer of value is
related to marketing, education, or research specific to
a covered drug, device, biological, or medical supply,
the name of that covered drug, device, biological, or
medical supply.
(viii) Any other categories of information regarding
the payment or other transfer of value the Secretary
determines appropriate.